Abstract:
The disclosure pertains to methods for modifying empathy in a subject, such as a human, by modulating type 2 theta oscillations in a brain region of the subject. The methods include increasing empathy in a subject, such as a human, by increasing type 2 theta oscillations in a brain region of the subject, thereby increasing empathy in the subject. The human subject may have a psychiatric or neurological condition that causes suboptimal empathy. Modulating type 2 theta oscillations in a brain region of a subject can be accomplished by optogenetic treatment, electric stimulation of a brain region, administration of a pharmaceutical drug, or a combination thereof. Also provided are systems for performing the methods disclosed herein.
Abstract:
The present invention relates to a method for producing immune-compatible cells or a cell population which comprises a step of editing one or two alleles of one or more immune-compatible antigen genes by gene deletion or modification in an isolated cell comprising at least one of the immune-compatible antigen genes selected from HLA (human leukocyte antigen)-A, HLA-B and HLA-DR, to immune-compatible cells produced by the method, and to a cell population comprising the immune-compatible cells produced by the method.
Abstract:
The present invention relates to an antibody that binds to human interleukin-2 (hIL-2), and more particularly to an anti-hIL-2 antibody that binds specifically to a particular epitope of hIL-2, thereby inhibiting the binding of the hIL-2 to CD25. The anti-hIL-2 antibody of the present invention binds specifically to a particular epitope of hIL-2, thereby inhibiting the binding of the hIL-2 to CD25, thereby minimizing expansion of Treg cells. In addition, it stimulates the CD8 + T cells and NK cells that exhibit anti-tumor activity. Thus, the anti-hIL-2 antibody of the present invention is useful as a new anticancer therapeutic agent.
Abstract:
Provided is a method of controlling release of nitrogen monoxide, and more particularly, a method of selectively releasing nitrogen monoxide using mesoporous silica nanoparticles including a material capable of emitting protons by light irradiation and calcium phosphate. The technique according to the present invention to control release of nitrogen monoxide by light irradiation may stably deliver nitrogen monoxide to a desired part, and induces release of nitrogen monoxide only when irradiated with light, thereby maximizing a therapeutic effect.
Abstract:
The present invention relates to method for preparing a plant from a protoplast comprising knocking-out or knocking-in one or more the endogenous gene of the protoplast, and the plant regenerated from a genome-modified protoplast prepared by the above method.
Abstract:
The present invention relates to an N-heterocyclic carbene nitric oxide radical, and an application thereof, and more particularly, to an N-heterocyclic carbene nitric oxide radical for effectively delivering nitric oxide having a desirable amount within a short period of time, a method for producing an N-heterocyclic carbene nitric oxide radical, and an application thereof.
Abstract:
Provided is a method of preparing a silylative-reduced N-heterocyclic compound by reducing an N-heteraromatic compound including a sp 2 hybridized nitrogen atom while simultaneously introducing a silyl group into a beta-position with respect to a nitrogen atom of the N-heteroaromatic compound, using a silane compound, in the presence of an organoboron catalyst.
Abstract:
Provided are a preparation method of a quinoline N- oxide derivative with an amide group capable of easily introducing the amide group into the quinoline N- oxide derivative by simplified processes and mild reaction conditions, and a quinoline N- oxide derivative with an amide group prepared by using the same.